 Food-Drug Interactions
"Food-Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed)
| Descriptor ID |
D018565
|
| MeSH Number(s) |
G07.690.812.240.511 G07.700.680.240.511
|
| Concept/Terms |
Food-Drug Interactions- Food-Drug Interactions
- Food Drug Interactions
- Food-Drug Interaction
- Interaction, Food-Drug
- Interactions, Food-Drug
- Drug-Food Interactions
- Drug Food Interactions
- Drug-Food Interaction
- Interaction, Drug-Food
- Interactions, Drug-Food
Food Interactions- Food Interactions
- Food Interaction
- Interaction, Food
- Interactions, Food
|
Below are MeSH descriptors whose meaning is more general than "Food-Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Food-Drug Interactions".
This graph shows the total number of publications written about "Food-Drug Interactions" by people in this website by year, and whether "Food-Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2017 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Food-Drug Interactions" by people in Profiles.
-
Chatelut E, Bruno R, Ratain MJ. Intraindividual Pharmacokinetic Variability: Focus on Small-Molecule Kinase Inhibitors. Clin Pharmacol Ther. 2018 06; 103(6):956-958.
-
Pergola PE, Spiegel DM, Warren S, Yuan J, Weir MR. Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study. Am J Nephrol. 2017; 46(4):323-332.
-
Parsad S, Ratain MJ. Food Effect Studies for Oncology Drug Products. Clin Pharmacol Ther. 2017 May; 101(5):606-612.
-
Szmulewitz RZ, Ratain MJ. Vemurafenib oral bioavailability: an insoluble problem. J Clin Pharmacol. 2014 Apr; 54(4):375-7.
-
Sharma MR, Karrison TG, Kell B, Wu K, Turcich M, Geary D, Kang SP, Takebe N, Graham RA, Maitland ML, Schilsky RL, Ratain MJ, Cohen EE. Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients. Clin Cancer Res. 2013 Jun 01; 19(11):3059-67.
-
Szmulewitz RZ, Ratain MJ. Playing Russian roulette with tyrosine kinase inhibitors. Clin Pharmacol Ther. 2013 Mar; 93(3):242-4.
-
Ratain MJ. Flushing oral oncology drugs down the toilet. J Clin Oncol. 2011 Oct 20; 29(30):3958-9.
-
Kang SP, Ratain MJ. Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products. Clin Cancer Res. 2010 Sep 01; 16(17):4446-51.
-
Shepard DR, Mani S, Kastrissios H, Learned-Coughlin S, Smith D, Ertel P, Magnum S, Janisch L, Fleming GF, Schilsky RL, Ratain MJ. Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil. Cancer Chemother Pharmacol. 2002 May; 49(5):398-402.
-
Falk RH, Decara JM. Dofetilide: a new pure class III antiarrhythmic agent. Am Heart J. 2000 Nov; 140(5):697-706.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|